Aaberg Thomas M
Department of Ophthalmology, Emory University School of Medicine, Atlanta, GA 30322, USA.
Arch Ophthalmol. 2010 Aug;128(8):1068-70. doi: 10.1001/archophthalmol.2010.150.
Although attempts were made ot reattach retinas using proliferative vitreoretinopathy by various techniques before the 1970s, it was the development and subsequent refinement of closed-eye, mechanized pars plana vitrectomy that initiated the rapid rise in the surgical success rate. This article presents a personal history of the milestone accomplishments that facilitated the strong possibility of success that patients with proliferative vitreoretinopathy can now anticipate. Currently, various gasses, chemical compounds, and pharmaceutical agents serve adjunctively to advance surgical techniques with the expectation that they may be the primary curative procedure in the future. As in the past, what is unconventional today may be common tomorrow.
尽管在20世纪70年代之前人们就尝试通过各种技术利用增殖性玻璃体视网膜病变来重新附着视网膜，但正是闭眼机械化玻璃体切割术的发展及其后续完善才使得手术成功率迅速提高。本文介绍了一系列具有里程碑意义的成就的个人经历，这些成就使得增殖性玻璃体视网膜病变患者现在有望获得很高的手术成功率。目前，各种气体、化合物和药物辅助推进手术技术，期望它们未来可能成为主要的治疗方法。就像过去一样，今天非传统的东西明天可能就会变得常见。
